Skip to main content

Month: May 2022

Kane Biotech Announces Update on Private Placement

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech,” or the “Company”), announced that its private placement of up to 10,000,000 common shares (“Shares”) at a price of $0.10 per Share for aggregate gross proceeds of up to $1,000,000, as previously announced on March 15, 2022 (the “Private Placement”), has been fully subscribed and is anticipated to close on May 16, 2022. Certain insiders of the Company are participating in the private placement, including Marc Edwards, the CEO of the Company. Mr. Edwards has agreed to purchase 3,100,000 Shares at a price of $0.10 per share for a total purchase price of $310,000. “I am excited to personally participate in this Private Placement as I saw...

Continue reading

Palisade Bio Announces $2.0 Million Registered Direct Offering

CARLSBAD, Calif., May 06, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (the “Company” or “Palisade Bio”), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3,646,690 shares of its common stock, at a purchase price of $0.55 per share. Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering. The closings of the sale of the securities in the financing is expected to occur on or about May 10, 2022, subject to the satisfaction of customary closing conditions. Palisade Bio intends to use the net proceeds from the financing for working capital and...

Continue reading

Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022

WOBURN, Mass., May 06, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial results for the three months ended March 31, 2022 before the opening of the U.S. financial markets on Friday, May 13, 2022 and will hold a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions. Conference Call and Webcast InformationEvent: Biofrontera Inc. First Quarter 2022 Financial Results and Business Update Conference CallDate: Friday, May 13, 2022Time: 11:00 a.m. Eastern timeConference call: 1-877-877-1275 (U.S.)1-412-858-5202 (international)Webcast: Live and 90-day replay webcast are available here and at www.investors.biofrontera-us.com.   About...

Continue reading

McEwen Mining Announces Senior Management Changes

TORONTO, May 06, 2022 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) (“McEwen Mining” or the “Company”) announces that Anna Ladd-Kruger, Chief Financial Officer, has decided to retire to focus on her health and family; she will depart after the first quarter reporting is complete and an orderly transition is in place. CFO responsibilities will be assumed on an interim basis by Perry Y. Ing until a new executive transitions into the position. Mr. Ing, CA, CPA, CFA, is an experienced executive who previously served as CFO of the Company and its predecessor from 2008 to 2015 and subsequently served as CFO of Kirkland Lake Gold and, most recently, of Mountain Province Diamonds. Additionally, Peter Mah, Chief Operating Officer, is stepping down for personal reasons on June 3rd. Responsibility for oversight of operations...

Continue reading

Navios Maritime Holdings Inc. Announces Redemption of $25.0 Million of 11.25% Senior Secured Notes due 2022

GRAND CAYMAN, Cayman Islands, May 06, 2022 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) (NYSE: NM), a global seaborne shipping and logistics company, announced that on May 6, 2022, the Company issued a notice of redemption with respect to an aggregate principal amount of $25,000,000 of its 11.25% Senior Secured Notes due 2022 (the “Notes”) at a redemption price equal to 100.00% of the aggregate principal amount thereof, plus accrued and unpaid interest to, but excluding, the redemption date of May 17, 2022. After this redemption, $105,000,000 in aggregate principal amount of Notes will remain outstanding. About Navios Holdings Navios Maritime Holdings Inc. (NYSE: NM) is a global seaborne shipping and logistics company focused on the transport and transshipment of dry bulk commodities including...

Continue reading

O2Micro Reports First Quarter 2022 Financial Results

GEORGE TOWN, Grand Cayman, May 06, 2022 (GLOBE NEWSWIRE) — Operational Highlights:2022 Q1 revenue was $21.6 million.GAAP net income was $0.03 per fully diluted ADSO2Micro expects the second quarter 2022 revenue to be in the range of $20.5 million to $22.7 million.O2Micro® International Limited (NASDAQ: OIIM)(O2Micro), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, reported its financial results today for the first quarter ending March 31, 2022. Financial Highlights for the First Quarter ending March 31, 2022: O2Micro reported the first quarter 2022 revenue of $21.6 million within the guidance announced on January 26, 2022. Revenue was down 6.9% from the same quarter in the previous year. The gross margin in the first quarter of 2022 was 52.6%, which was up...

Continue reading

Arbor Realty Trust Reports First Quarter 2022 Results and Increases Quarterly Dividend to $0.38 per Share

Company Highlights:Diversified, annuity-based operating platform with a multifamily focus that generates strong distributable earnings and dividends in all cyclesGAAP net income of $0.40 and distributable earnings of $0.55 per diluted common share1 Raised cash dividend on common stock to $0.38 per share, our 8th consecutive quarterly increase representing a 27% increase over that span Successfully raised $215 million of accretive capital and increased warehouse capacity by $400 million to fund the significant growth of our structured portfolioStructured Business:Portfolio growth of 17% from strong loan originations of $2.83 billion Closed a $2.05 billion collateralized securitization vehicleAgency Business:Loan originations of $838.5 million and a servicing portfolio of $27 billion Closed our 4th private label securitization...

Continue reading

Cogent Biosciences to Participate in the LifeSci Partners Immunology and Inflammation Symposium

CAMBRIDGE, Mass. and BOULDER, Colo., May 06, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that management will participate in a fireside chat at the LifeSci Partners Immunology and Inflammation Symposium on Tuesday, May 10, 2022 at 3:30 p.m. ET. A live audio webcast will be available through the Investors and Media section of the Cogent website at https://investors.cogentbio.com/events. An archived replay will be available on the Company’s website for 30 days. About Cogent Biosciences, Inc.Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor...

Continue reading

Abercrombie & Fitch Co. to Report First Quarter 2022 Results on May 24, 2022

NEW ALBANY, Ohio, May 06, 2022 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Tuesday, May 24, 2022, at 8:30 a.m. ET. A press release detailing the company’s first quarter results is expected to be issued shortly after 7:30 a.m. ET.   In addition, a presentation of the first quarter results will be available on the company’s website at approximately 7:30 a.m. ET.  What: Abercrombie & Fitch Co. First Quarter 2022 Earnings Conference Call       When: 8:30 a.m. ET, Tuesday, May 24, 2022       Where: http://corporate.abercrombie.com/investors       How: Log on to the above website, or call:         Domestic Dial-In Number: 1-800-458-4121    Domestic Replay Number: 1-888-203-1112, conference ID number 5209585         International...

Continue reading

SmileDirectClub Adds New Wireless Kit To Innovative Whitening Portfolio

Latest Expansion Hits the Shelves of Nearly 4,000 Walmart Stores NationwideWireless Premium Teeth Whitening Kit Wireless Premium Teeth Whitening KitNASHVILLE, Tenn., May 06, 2022 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, announces the expansion of its best-in-class oral care product offerings with its new Wireless Premium Teeth Whitening Kit. SmileDirectClub’s latest premium affordable whitening treatment combines two of the brand’s most innovative oral care accessories; a convenient 6 mL whitening gel pen and a rechargeable, reusable patented Wireless LED Whitening Light to brighten teeth up to 9 shades in a week. The new gel pen includes more gel than 4 standard pens and is enamel-safe with low sensitivity. Thanks...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.